Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gottlieb

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Pathology|September 17, 2011
Mobilisation strategies for normal and malignant cellsL Bik To, Jean-Pierre Levesque, Kirsten E Herbert, et al.
Blood|January 29, 2021
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxisGlen A Kennedy, Siok-Keen Tey, Luke Buizen, et al.
British Journal of Haematology|September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphomaForat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Blood Advances|November 1, 2021
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignanciesConstantine S Tam, Meletios Dimopoulos, Ramon Garcia-Sanz, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Heliyon|April 24, 2023
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest groupHuisheng Ai, Nelson J Chao, David A Rizzieri, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Pathology|September 17, 2011
Mobilisation strategies for normal and malignant cellsL Bik To, Jean-Pierre Levesque, Kirsten E Herbert, et al.
Blood|January 29, 2021
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxisGlen A Kennedy, Siok-Keen Tey, Luke Buizen, et al.
British Journal of Haematology|September 9, 2021
The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphomaForat Lutfi, Noa G Holtzman, Ankit J Kansagra, et al.
Blood Advances|November 1, 2021
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignanciesConstantine S Tam, Meletios Dimopoulos, Ramon Garcia-Sanz, et al.
Internal Medicine Journal|August 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statementNada Hamad, Michelle Ananda-Rajah, Nicole Gilroy, et al.
Heliyon|April 24, 2023
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest groupHuisheng Ai, Nelson J Chao, David A Rizzieri, et al.
Pageof 9